Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.1 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.045 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |